Chou Ping-Song, Ho Bo-Lin, Chan Yi-Hsin, Wu Min-Hsien, Hu Han-Hwa, Chao A-Ching
Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Department of Neurology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Intern Med J. 2018 Jun;48(6):661-667. doi: 10.1111/imj.13686.
Delayed detection of atrial fibrillation (AF) is common in patients with stroke. However, it is not well known whether delayed identification of AF in patients with stroke affects the prognosis of patients.
To evaluate the association between the timing of AF diagnosis after stroke and clinical outcomes.
We identified a cohort of all patients admitted with a primary diagnosis of first-ever ischaemic stroke, which was categorised into three groups, namely, non-AF, AF presenting with stroke and delayed AF diagnosis groups. The study patients were individually followed for 5 years to evaluate the occurrence of recurrent stroke and death.
In total, 17 399 patients were hospitalised with first-ever ischemic stroke, of whom 16 261 constituted the non-AF group, 907 the AF presenting with stroke group and 231 the delayed AF diagnosis group. During the 5-year follow up, 2773 (17.1%), 175 (19.3%) and 68 (29.4%) patients in the non-AF, AF presenting with stroke and delayed AF diagnosis groups, respectively, were hospitalised for recurrent stroke. The delayed AF diagnosis group exhibited a 1.57-times higher risk of recurrent stroke than the AF presenting with stroke group, after adjustment for the CHA2DS2-VASc scores (adjusted hazard ratio (HR): 1.57; 95% confidence interval (CI) = 1.19-2.08; P = 0.002). In addition, delayed diagnosis of AF significantly increased the risk of recurrent stroke in men, but not in women, after adjustment for the CHA2DS2-VASc scores.
Delayed diagnosis of AF after stroke increased the risk of recurrent stroke, particularly in men.
房颤(AF)的延迟检测在卒中患者中很常见。然而,卒中患者中房颤的延迟识别是否会影响患者的预后尚不清楚。
评估卒中后房颤诊断时间与临床结局之间的关联。
我们确定了一组以首次缺血性卒中为主要诊断入院的所有患者,将其分为三组,即非房颤组、卒中伴房颤组和房颤延迟诊断组。对研究患者进行了5年的个体随访,以评估复发性卒中和死亡的发生情况。
共有17399例患者因首次缺血性卒中住院,其中16261例构成非房颤组,907例为卒中伴房颤组,231例为房颤延迟诊断组。在5年随访期间,非房颤组、卒中伴房颤组和房颤延迟诊断组分别有2773例(17.1%)、175例(19.3%)和68例(29.4%)患者因复发性卒中住院。在调整CHA2DS2-VASc评分后,房颤延迟诊断组复发性卒中的风险比卒中伴房颤组高1.57倍(调整后的风险比(HR):1.57;95%置信区间(CI)=1.19-2.08;P=0.002)。此外,在调整CHA2DS2-VASc评分后,房颤延迟诊断显著增加了男性复发性卒中的风险,但对女性没有影响。
卒中后房颤延迟诊断增加了复发性卒中的风险,尤其是在男性中。